MARKET NEWS

Takeda & Arrowhead Collaborate to Co-Develop & Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease
Vaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine
uniQure Announces Enrollment of Next Two Patients in Phase 1/2 Clinical Trial
Mogrify Introduces Platform to Systematically Identify Epigenetic Switches Driving Cell Identity & Cell Maintenance
NapaJen Pharma Reports Positive Results From Phase 1 Clinical Trial of Novel RNAi Therapeutic
Cambrex Completes Major Expansion of Solid Form Screening Facility

  FEATURED EDITORIAL

  COMPANY PROFILE

Capsule Delivery Solutions, part of Lonza Pharma & Biotech, is the leader in capsule-based solutions and services, proudly offering Capsugel products. With the largest production and supply chain footprint in the industry, Capsule Delivery Solutions provides the highest quality and deepest regulatory expertise to its 2,000 pharmaceutical customers, globally. Our unique combination of science, engineering, formulation and capsule expertise enables us to optimize the bioavailability, targeted delivery and overall performance of our customer’s products. We partner with them in over 100 countries to create novel, high-quality and customized solutions that meet their needs and patients’ evolving preferences. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Scientific Management of Pharmaceutical Container Closure & Delivery Device Compatibility

Scientific Management of Pharmaceutical Container Closure & Delivery Device Compatibility

Diane Paskiet says the relationship between pharmaceutical products and CC/DD is best managed through a rich science-based approach that factors in potential risk and is adapted early in the development process.

MilliporeSigma’s New Platform Speeds Development of Cell & Gene Therapies

MilliporeSigma’s New Platform Speeds Development of Cell & Gene Therapies

MilliporeSigma has recently bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress Lentiviral Production Platform…..

Cytovia Therapeutics Partners Enters Research & Licensing Agreement With Inserm

Cytovia Therapeutics Partners Enters Research & Licensing Agreement With Inserm

Cytovia Therapeutics recently announced it has entered a research and licensing agreement with Inserm to develop NK engager bi-specific antibodies and iPSC CAR NK cell therapy targeting….

WEBINAR SERIES ALERT - Learn About Complex Parenteral Drug Delivery From Evonik Industry Experts - Free Oct-Nov Webinar Series

WEBINAR SERIES ALERT - Learn About Complex Parenteral Drug Delivery From Evonik Industry Experts - Free Oct-Nov Webinar Series

As a global CDMO leader for advanced drug delivery, Evonik invites you to join us for a webinar series on parenteral drug delivery. More than a dozen technical experts from Evonik will review….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

October 28 – Analytical Testing
November 4 – Formulation Development